Skip to main content
. 2023 May 12;28(10):4042. doi: 10.3390/molecules28104042

Figure 2.

Figure 2

Figure 2

The change in splenic-hepatic inflammatory factors and hepatic cholesterol-metabolizing enzymes’ expression levels and intestinal microbiota in NAFLD mice. (A) The mRNA expression of inflammatory factors in the spleen. (B) mRNA expression of cholesterol-metabolizing enzymes in the liver. (C) The mRNA expression of liver-fibrosis-related indicators. Data are presented as the mean ± SD (n = 10). a: Compared with the NC group, p < 0.05; b: compared with the HF group, p < 0.05.